Clinical Trials
48
Active:2
Completed:32
Trial Phases
5 Phases
Early Phase 1:1
Phase 1:1
Phase 2:8
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (45 trials with phase data)• Click on a phase to view related trials
Not Applicable
30 (66.7%)Phase 2
8 (17.8%)Phase 3
5 (11.1%)Early Phase 1
1 (2.2%)Phase 1
1 (2.2%)Text Messaging to Promote HIV Testing in Gay Men
Not Applicable
Completed
- Conditions
- HIV Testing
- First Posted Date
- 2025-09-10
- Last Posted Date
- 2025-09-10
- Lead Sponsor
- Universidad Peruana Cayetano Heredia
- Target Recruit Count
- 400
- Registration Number
- NCT07165496
- Locations
- 🇵🇪
Universidad Peruana Cayetano Heredia, Lima, Lima Province, Peru
Implementation of the COmmunity HEalth System InnovatiON Project in Low- and Middle- Income Countries
Not Applicable
Not yet recruiting
- Conditions
- HypertensionDiabetes MellitusNeglected Tropical Diseases
- First Posted Date
- 2025-05-25
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- Universidad Peruana Cayetano Heredia
- Target Recruit Count
- 2094
- Registration Number
- NCT06989502
- Locations
- 🇲🇿
Eduardo Mondlane University, Maputo, Mozambique
🇳🇵B.P. Koirala Institute of Health Sciences, Dharān Bāzār, Nepal
🇵🇪Universidad Peruana Cayetano Heredia, Piura, Peru
Oxfendazole in Mild Parenchymal Brain Cysticercosis
Phase 2
Not yet recruiting
- Conditions
- Brain Cysticercosis
- Interventions
- First Posted Date
- 2024-08-22
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Universidad Peruana Cayetano Heredia
- Target Recruit Count
- 544
- Registration Number
- NCT06565507
WhatsApp Intervention to Assess the Effect of Messages in Adherence to Antiretrovirals in Young People with HIV in Peru
Not Applicable
Active, not recruiting
- Conditions
- HIV
- First Posted Date
- 2024-07-15
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- Universidad Peruana Cayetano Heredia
- Target Recruit Count
- 131
- Registration Number
- NCT06500013
- Locations
- 🇵🇪
Hospital Cayetano Heredia, Lima, Peru
One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole in Chronic Fascioliasis
- First Posted Date
- 2024-04-16
- Last Posted Date
- 2025-06-17
- Lead Sponsor
- Universidad Peruana Cayetano Heredia
- Target Recruit Count
- 336
- Registration Number
- NCT06367361
- Prev
- 1
- 2
- 3
- 4
- 5
- 10
- Next
News
No news found